-
Clinical Trial Shows Combination Therapy May Benefit Teens with Type 1 Diabetes
20 Jun 2025 09:38 GMT
… trial has found that combining standard insulin therapy with the investigational drug … . While insulin remains essential for treatment, long-term use can lead … in youth with type 1 diabetes: a randomized controlled trial. Nat Med (2025). https:…
-
Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more
20 Jun 2025 15:35 GMT
… develop novel cancer therapeutics targeting FTSJ1.
FDA:
Dyne Therapeutics received FDA … period of new drugs from 10- … Pharmaceuticals laid off 125 of its employees after a failed type 1 diabetes … blood cancer treatment trial testing the drug Venclexta.
However …
-
Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes
20 Jun 2025 05:36 GMT
… -2 trial evaluating HDV-Insulin Lispro in adults with Type 1 diabetes.
OPTI … throughout the course of treatment to capture detailed glycemic … States.
About Diasome Pharmaceuticals
Diasome Pharmaceuticals is developing HDV™—a proprietary phospholipid …
-
Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes
19 Jun 2025 15:09 GMT
… changes, psychological developments, and shared … pharmacy colleagues with the latest drug … type-1-diabetes
3. Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial … type 1 diabetes: a randomized controlled trial. Nat Med …
-
C-Path’s TRxA awards $250,000 grant to develop novel treatment for type 1 diabetes
19 Jun 2025 11:47 GMT
… grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Kyle Apley … for patients with type 1 diabetes. This grant and the drug discovery expertise at … T1D to improve clinical trial design, accelerate development of new therapies, and …
-
C-Path’s translational therapeutics accelerator announces new grant award for drug development project in type 1 diabetes
19 Jun 2025 02:07 GMT
… aimed at developing a novel treatment for type 1 diabetes (T1D). … improve clinical trial design, accelerate development of new therapies … response to the FDA’s Critical Path … based labs to drug development pipelines of pharmaceutical companies and, …
-
GLP-1 drugs and eye health risks: A new watchlist for diabetes patients
19 Jun 2025 23:56 GMT
… medications faced more than double the risk of developing … Optometrist Meenal Agarwal, who treats diabetic patients, reinforced the … monitoring: “Don’t stop treatment abruptly. Instead, engage in … . Patricia Welter, a type 1 diabetes patient who lost an …
-
Clinical trial for teens shows improved health outcomes for type 1 diabetes
17 Jun 2025 23:38 GMT
A clinical trial involving adolescents with type 1 diabetes (T1D) has … standard insulin treatment with the investigational drug dapagliflozin. … disease. In the trial, participants who received … Hormonal changes, psychological development, and the shared …
-
Type 1 Diabetes Market Size to Reach USD 9.6 billion by 2035 | Epidemiology, Treatment, Trends & Rising Incidence
17 Jun 2025 14:29 GMT
… type 1 diabetes marketed drugs and late-stage pipeline drugs, advancements in treatment … Type 1 diabetes is Technology. Development … drugs.
In-Market Drugs
Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug … Pharmaceuticals …
-
Ed Gamble: ‘‘Type 1 diabetes — it’s like having two jobs’’
17 Jun 2025 01:29 GMT
… very best to turn his type 1 diabetes to his advantage. “There’s … with lifestyle changes and oral medication.
Type 1s must follow a … cent of type 1s will develop a serious condition such as …